FDA changes deserve a closer read.

What the team gets

Regulatory updates live across several official systems. The watch connects the relevant records to the products and molecules your team follows and prioritizes changes for review.

• Application and approval activity from Drugs@FDA and Orange Book records
• Drug label and section changes from DailyMed and openFDA
• Safety-related labeling changes, recalls, and shortages
• Selected advisory committee, REMS, postmarketing and accelerated approval records

Where the evidence comes from

The source map names each FDA and DailyMed feed separately, with official links and caveats. The exact set included in a watch depends on the asset and coverage check.

Drugs@FDA · DailyMed · FDA safety labeling changes

Explore the full source map for more detail about the underlying data.

How the read is used

Watchtower surfaces the change, why it may matter to the watched asset, and the underlying record. Your team decides what to investigate or circulate. See a source-linked example.

An updated label can contain clinical, safety, or administrative changes. A source update is a prompt for review, not a conclusion about clinical significance.